Investigation into alternative testing methodologies for characterization of influenza virus vaccine

References

• WHO. Influenza (seasonal) fact sheet no. 211. http://www.who.int/mediacentre/factsheets/fs211/en/index.html (2009); Accessed on 10th January 2014
   Google Scholar
• Bernstein DI, Zahradnik JM, DeAngelis CJ, Cherry JD. Clinical reactions and serological responses after vaccination with whole-virus or split-virus influenza vaccines in children agred 6 to 36 months. Pediatrics 1982; 69:404-8; PMID:7070886
   PubMed Web of Science ®Google Scholar
• Gross PA, Ennis FA, Gaerlan PF, Denson LJ, Denning CR, Schiffman D. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis 1977; 136:623-32; PMID:335000; http://dx.doi.org/10.1093/infdis/136.5.623
   PubMed Web of Science ®Google Scholar
• Furminger IGS. Vaccine production. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of Influenza. Oxford: Blackwell Science, 1998:324-32
   Google Scholar
• Hoyle L, Barker SM. Fractionation of the influenza virus with the object of producing subunit vaccine. Postgrad Med J 1973; 49:193-94; PMID:4802482; http://dx.doi.org/10.1136/pgmj.49.569.193
   PubMed Web of Science ®Google Scholar
• Scheid A, Caliguiri LA, Compans RW, Choppin PW. Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology 1972; 50:640-52; PMID:4118317; http://dx.doi.org/10.1016/0042-6822(72)90418-7
   PubMed Web of Science ®Google Scholar
• EP. Monographs on vaccines for human use – influenza vaccine (split virion, inactivated). Monograph no. 01/2008:0158. European Pharmacopoeia (8th Edn) 2013; 1:861-63
   Google Scholar
• Pharmaceutical suspensions. In: Mahato RI, ed. Pharmaceutical Dosage Forms and Drug Delivery. Boca Raton, FL, USA: CRC Press, 2007:123-33
   Google Scholar
• EP. Monographs on dosage forms – Parenteral preparations injections. European Pharmacopoeia (8th Edn) 2013; 1:796-97
   Google Scholar
• FDA. Guidance for industry – immunogenicity assessment for therapeutic protein products. Food Drug Admin 2014:1-36
   Google Scholar
• EMA. Guideline on influenza vaccines – quality module. Eur Med Agency Sci Med Health 2014:1-34
   Google Scholar
• Webster RG, Granoff A. Encyclopedia of virology. In: Palese P, Garciá-Sastre A, eds. Influenza Viruses: Molecular Biology. San Diego, CA: Academic Press, 1994
   Google Scholar
• Mie G. Beiträge zur Optik trüber Medien, speziell kolloidaler Metallösungen. Annalen der Physik 1908; 330:377-445; http://dx.doi.org/10.1002/andp.19083300302
   Google Scholar
• Finke JM, Roy M, Zimm BH, Jennings PA. Aggregation events occur prior to stable intermediate formation during refolding of interleukin 1beta. Biochemistry 2000; 39:575-83; PMID:10642182; http://dx.doi.org/10.1021/bi991518m
   PubMed Web of Science ®Google Scholar
• Lomakin A, Teplow DB, Kirschner DA, Benedek GB. Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci USA 1997; 94:7942-47; PMID:9223292; http://dx.doi.org/10.1073/pnas.94.15.7942
   PubMed Web of Science ®Google Scholar
• Gupta P, Hall CK, Voegler AC. Effect of denaturant and protein concentrations upon protein refolding and aggregation: a simple lattice model. Protein Sci 1998; 7:2642-52; PMID:9865959; http://dx.doi.org/10.1002/pro.5560071218
   PubMed Web of Science ®Google Scholar
• Aitken A, Learmonth MP. Protein determination by UV absorption. In: Walker JM, ed. The Protein Protocols Handbook. Totowa, NJ, USA: Humana Press Inc., 2002:3-6
   Google Scholar
• Wang W, Wang YJ, Wang DQ. Dual effects of Tween 80 on protein stability. Int J Pharm 2008; 347:31-38; PMID:17692480; http://dx.doi.org/10.1016/j.ijpharm.2007.06.042
   PubMed Web of Science ®Google Scholar
• Philo JS. A critical review of methods for size characterization of non-particulate protein aggregates. Curr Pharm Biotechnol 2009; 10:359-72; PMID:19519411; http://dx.doi.org/10.2174/138920109788488815
   PubMed Web of Science ®Google Scholar
• Striegel AM. Thermodynamic equilibrium of the solute distribution in size-exclusion chromatography. J Chromatogr 2004; 1033:241-45; http://dx.doi.org/10.1016/j.chroma.2004.01.040
   Web of Science ®Google Scholar
• Calvin GJ. The Field-Flow Fractionation Family: Underlying Principles. New York, NY: John Wiley & Sons, 2000
   Google Scholar
• Laue TM, Stafford WF. Modern applications of analytical ultracentrifugation. Annu Rev Biophys Biomol Struct 1999; 28:75-100; PMID:10410796; http://dx.doi.org/10.1146/annurev.biophys.28.1.75
   PubMedGoogle Scholar
• Reschiglian P, Zattoni A, Roda B, Michelini E, Roda A. Field-flow fractionation and biotechnology. Trends Biotechnol 2005; 23:475-83; PMID:16061297; http://dx.doi.org/10.1016/j.tibtech.2005.07.008
   PubMed Web of Science ®Google Scholar
• Schuster TM, Toedt JM. New revolutions in the evolution of analytical ultracentrifugation. Curr Opin Struct Biol 1996; 6:650-58; PMID:8913688; http://dx.doi.org/10.1016/S0959-440X(96)80032-7
   PubMed Web of Science ®Google Scholar
• Pekar AH, Frank BH. Conformation of proinsulin. A comparison of insulin and proinsulin self-association at neutral pH. Biochemistry 1972; 11:4013-16; PMID:4673642; http://dx.doi.org/10.1021/bi00772a001
   PubMed Web of Science ®Google Scholar
• Brems DN, Alter LA, Beckage MJ, Chance RE, DiMarchi RD, Green LK, Long HB, Pekar AH, Shields JE, Frank BH. Altering the association properties of insulin by amino acid replacement. Protein Eng 1992; 5:527-33; PMID:1438163; http://dx.doi.org/10.1093/protein/5.6.527
   PubMedGoogle Scholar
• Giddings JC. Field-flow fractionation: analysis of macromolecular, colloidal, and particulate materials. Science 1993; 260:1456-65; PMID:8502990; http://dx.doi.org/10.1126/science.8502990
   PubMed Web of Science ®Google Scholar
• Wahlund KG, Litzen A. Application of an asymmetrical flow field-flow fractionation channel to the separation and characterization of proteins, plasmids, plasmid fragments, polysaccharides and unicellular algae. J Chromatogr 1989; 461:73-87; PMID:2708482; http://dx.doi.org/10.1016/S0021-9673(00)94276-6
   PubMed Web of Science ®Google Scholar
• Liu MK, Li P, Giddings JC. Rapid protein separation and diffusion-coefficient measurement by frit inlet flow field-flow fractionation. Protein Sci 1993; 2:1520-31; PMID:8401236; http://dx.doi.org/10.1002/pro.5560020917
   PubMed Web of Science ®Google Scholar
• Nobbmann U, Connah M, Fish B, Varley P, Gee C. Dynamic light scattering as a relative tool for assessing the molecular integrity and stability of monoclonal antibodies. Biotechnol Genet Eng Rev 2007; 24:117-28; PMID:18059629; http://dx.doi.org/10.1080/02648725.2007.10648095
   PubMedGoogle Scholar
• Malvern. Dynamic light scattering: common terms defined. Malvern Instruments Limited 2011:1-6
   Google Scholar
• bioCSL. Fluvax® vaccine SH 2014 Product Information. http://www.biocsl.com.au/docs/314/677/20130930_SH2014%20Fluvax%20vaccine%20PI_clean_JT_T_dated.pdf (October 2013); Accessed on 29th December 2014
   Google Scholar
• Hayat MA, Miller SE. Negative Staining. New York: McGraw-Hill, 1990
   Google Scholar
• Esfandiary R, Middaugh CR. Ultraviolet absorption spectroscopy. In: Mahler H-C, Jiskoot W, eds. Analysis of aggregates and particles in protein pharmaceuticals. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2012:171-200
   Google Scholar